Specific IgE Component Analysis for Peanut: Dissecting Ara h 1, Ara h 2, Ara h 3, and Ara h 8 Clinical Risk Levels
Peanut allergy is one of the most clinically discussed food sensitivities in the UK, yet a standard total IgE blood test often provides only a partial picture. Specific IgE component analysis for peanut — examining individual molecular allergens such as Ara h 1, Ara h 2, Ara h 3, and Ara h 8 — allows for a significantly more nuanced understanding of an individual's immune reactivity profile. This type of component-resolved diagnostic (CRD) testing is becoming increasingly available through private screening services and is regarded as a meaningful step forward in allergy risk stratification.
This educational guide explores what each peanut component marker may indicate, who might consider this level of testing, and how results can support more informed conversations with healthcare professionals.
What Is Specific IgE Component Testing for Peanut?
Specific IgE peanut component testing is a blood-based investigation that measures the immune system's IgE antibody response to individual proteins found within the peanut. Rather than testing for peanut as a whole extract, component testing identifies reactivity to precise molecular fractions — each associated with different levels of clinical relevance.
Definition: Peanut component IgE testing analyses distinct allergen proteins (Ara h 1, 2, 3, 8, and others) to provide a more granular view of sensitisation. Results may help distinguish between genuine systemic reactivity and cross-reactive sensitisation, though interpretation should always involve an appropriate healthcare professional.
Understanding the Four Key Peanut Allergen Components
Ara h 1 — A Stable Storage Protein
Ara h 1 is a vicilin-class storage protein that is relatively heat-stable, meaning it largely retains its allergenic structure even after cooking or processing. Sensitisation to Ara h 1, particularly in combination with other storage proteins, may suggest a heightened likelihood of systemic immune involvement. It is considered one of the major peanut allergens frequently identified in individuals with confirmed peanut reactivity.
Practical Insight: Elevated Ara h 1 IgE alone does not confirm a diagnosis — it is one piece of a broader immunological picture that should be interpreted alongside clinical history and other markers.
Ara h 2 — The Most Clinically Significant Marker
Among all peanut components, Ara h 2 is widely regarded as the single most clinically informative marker. It is a 2S albumin seed storage protein with a highly stable structure resistant to digestion and heat. Research consistently highlights Ara h 2 sensitisation as being strongly associated with systemic immune reactions in individuals with confirmed peanut allergy.
For this reason, Ara h 2 specific IgE is often considered a primary focus in component-resolved diagnostic panels. A measurable IgE response to Ara h 2 can suggest more significant systemic sensitisation compared to cross-reactive markers such as Ara h 8.
Practical Insight: Ara h 2 levels are frequently discussed in allergy literature as a useful marker for risk stratification, though all results require professional clinical interpretation in the context of the individual's full history.
Ara h 3 — A Secondary Storage Protein
Ara h 3 is a legumin-type storage protein with structural similarities to allergens found in other legumes such as soy and lupin. Like Ara h 1, it is relatively heat-stable. Sensitisation to Ara h 3, when detected alongside Ara h 1 and Ara h 2, may indicate a broader sensitisation profile involving multiple peanut storage proteins.
Ara h 3 is considered a minor-to-moderate allergen in terms of independent clinical significance, but its presence in a component panel adds contextual information about the breadth of an individual's sensitisation.
Practical Insight: Isolated Ara h 3 sensitisation without co-sensitisation to Ara h 2 is less common in confirmed systemic cases. Panel interpretation should always be holistic.
Ara h 8 — The Cross-Reactive PR-10 Protein
Ara h 8 is structurally homologous to Bet v 1, the major birch tree pollen allergen. This makes Ara h 8 a cross-reactive allergen rather than a primary peanut storage protein. Individuals sensitised primarily to Ara h 8 — often those with birch pollen sensitivity — may experience mild oral symptoms (sometimes referred to as oral allergy syndrome or pollen-food allergy syndrome) rather than systemic reactions.
Ara h 8 sensitisation without co-sensitisation to Ara h 2 is generally considered to suggest a lower clinical risk profile, though this should not be self-interpreted. Context remains essential.
Practical Insight: A positive result for Ara h 8 alongside negative results for Ara h 1, 2, and 3 may suggest a cross-reactive sensitisation pattern associated with pollen allergy — but professional assessment is always advised before drawing conclusions.
Comparison Table: Peanut Allergen Components at a Glance
| Component | Protein Class | Heat Stability | Clinical Relevance | Common Association |
|---|---|---|---|---|
| Ara h 1 | Vicilin (storage) | High | Moderate–High | Major systemic allergen |
| Ara h 2 | 2S Albumin (storage) | Very High | High | Strongest systemic marker |
| Ara h 3 | Legumin (storage) | High | Moderate | Broader storage protein sensitisation |
| Ara h 8 | PR-10 protein | Low | Lower (cross-reactive) | Birch pollen cross-reactivity |
This table is for educational reference only. Clinical interpretation requires professional assessment.
Who Might Consider Peanut Component IgE Testing?
Peanut component testing may be relevant for individuals who:
- Have previously received a positive total peanut IgE result and want greater clarity
- Experience reactions to peanut-containing foods but have not undergone component-level assessment
- Have known birch pollen sensitivity and are uncertain whether peanut reactions are systemic or cross-reactive
- Are seeking a more detailed understanding of their immune sensitisation profile for personal awareness
- Have family members with documented peanut allergy and wish to understand their own profile
At our London allergy screening clinic, we offer blood-based specific IgE component testing as part of our adult and children's allergy screening services. Our nurse-led team provides testing and detailed written reporting — all results are accompanied by a report to support your next steps with an appropriate healthcare professional.
How Often Should Component Testing Be Considered?
There is no universal frequency guideline for peanut component IgE retesting. However, repeat testing may be considered in the following circumstances:
- When initial results were obtained during childhood and circumstances have changed
- When there has been a meaningful change in reported reactivity patterns
- When new clinical information suggests reassessment would be beneficial
Decisions about repeat testing should always be guided by the clinical context and in consultation with an appropriate healthcare professional.
What Do Peanut Component IgE Results Mean?
A positive IgE result for any peanut component indicates immunological sensitisation — meaning the immune system has produced specific IgE antibodies in response to that allergen protein. It is important to understand that:
- Sensitisation does not automatically equate to clinical allergy
- Not all sensitised individuals experience symptoms upon exposure
- The clinical significance of results depends on the specific component, the level of reactivity, and the individual's history
Results are provided in kUA/L (kilounits of allergen per litre) and are typically classified across standard reactivity bands. Our screening reports provide clearly explained result summaries to support your healthcare conversations.
You may also find our resources on food allergy blood testing and understanding IgE sensitisation helpful for further context.
Peanut Allergy Testing in London: A Private Screening Option
For adults and families across London seeking a clearer picture of their allergy sensitisation profile, private component IgE testing offers an accessible route to more detailed information without the typical wait associated with NHS referral pathways.
Our nurse-led clinic provides straightforward blood testing and professionally prepared reports. We do not offer prescriptions, treatment plans, or specialist allergy consultations — our role is to provide accurate, clearly communicated screening data that empowers you to have better-informed conversations with your GP or any other healthcare professional you choose to engage.
Explore our allergy testing services and IgE blood testing options to learn more about what we offer.
Frequently Asked Questions
1. What is specific IgE component analysis for peanut?
Specific IgE component analysis for peanut is a blood test that measures the immune system's antibody response to individual peanut proteins — such as Ara h 1, Ara h 2, Ara h 3, and Ara h 8 — rather than peanut as a whole. This approach may provide more detailed information about an individual's sensitisation profile than a standard total peanut IgE test.
2. Why is Ara h 2 considered the most important peanut component marker?
Ara h 2 is a highly stable 2S albumin protein that resists heat and digestion. It is widely regarded in allergy literature as the component most strongly associated with systemic sensitisation. Elevated Ara h 2 IgE may suggest a more clinically significant reactivity profile, though all results require professional interpretation.
3. What does a positive Ara h 8 result mean?
A positive Ara h 8 result may indicate cross-reactive sensitisation linked to birch pollen allergy rather than primary peanut sensitisation. Individuals sensitised primarily to Ara h 8 are sometimes associated with milder oral symptoms rather than systemic reactions, though this should always be assessed by a healthcare professional.
4. Can I have the test if I have never had a confirmed peanut reaction?
Yes. Adults with personal or family history concerns, or those who have had uncertain or borderline results previously, may choose to undergo component testing for informational awareness. Our clinic provides testing and reporting — we recommend discussing results with your GP or relevant healthcare professional.
5. Is peanut component IgE testing available on the NHS?
Component-resolved diagnostic testing is available through some NHS allergy services, typically following specialist referral. Private screening clinics such as ours offer this testing with shorter waiting times and detailed written reports.
6. How is the blood sample taken?
A small venous blood sample is taken by our trained nurses. The sample is sent to an accredited UK laboratory for analysis. Results are typically available within a few working days and are provided with a clear written report.
7. Will the results tell me whether I am allergic to peanuts?
Results indicate the presence and level of specific IgE antibodies to peanut components. Sensitisation does not automatically mean clinical allergy. A diagnosis of peanut allergy requires clinical assessment by an appropriate healthcare professional, taking into account your history, symptoms, and test results collectively.
8. Can children be tested using this method?
Specific IgE component blood testing is used in paediatric allergy assessment. Please contact our clinic to discuss suitability and any age-specific considerations. Our team will advise on the most appropriate testing pathway.
9. How do I interpret the kUA/L values on my report?
Results are expressed in kUA/L and classified across reactivity bands (e.g., low, moderate, high). Our reports include explanatory notes for each result. We strongly recommend discussing your full report with a GP or healthcare professional who can contextualise findings within your clinical history.
10. Does a low Ara h 2 result mean I am not allergic to peanuts?
A low or undetectable Ara h 2 IgE level does not conclusively exclude peanut allergy, as reactions may involve other components or mechanisms. All results should be interpreted as part of a broader clinical picture by an appropriate healthcare professional.
EEAT Authority Note
This article has been written by a senior UK medical content writer with specialist knowledge in preventive health screening, diagnostic blood testing, and allergy sensitisation. Content is based on peer-reviewed allergy literature, established component-resolved diagnostic principles, and UK clinical communication standards. All guidance is intended for educational purposes only. This clinic is a nurse-led testing and screening service — we do not provide diagnosis, treatment, or prescriptions.
Take the Next Step in Understanding Your Allergy Profile
If you are seeking clearer information about your peanut sensitisation profile, component IgE testing may offer valuable insights. Our nurse-led screening clinic in London offers accessible, professional allergy blood testing with detailed written reports — no referral required.
Explore our allergy testing options and take a proactive step towards better-informed health awareness at your own pace.
Disclaimer
This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. The content presented here should not replace consultation with a qualified healthcare professional. Individual symptoms, health concerns, or test results should always be assessed by an appropriate and suitably qualified healthcare professional. This clinic provides testing and screening services only — we do not offer prescriptions, treatment plans, or clinical diagnoses. No guarantees of health outcomes are expressed or implied. If you are experiencing severe or urgent symptoms, please seek immediate medical attention.
